Clinical Trial Update: Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and blood pressure lowering with a combined angiotensin receptor blocker and calcium antagonist in hypertension has been withdra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Angiotensin receptor blocker + calcium antagonist

Snippet

Sponsor: Monash University | Conditions: Hypertension | Phase 4 | Status: WITHDRAWN